x |
Quarterly
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
for the quarterly period ended June 30,
2006.
|
¨ |
Transition
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Delaware
(State
or other Jurisdiction of
Incorporation
or Organization)
|
77-0312442
(I.R.S.
Employer Number)
|
PART
I - FINANCIAL INFORMATION
|
||
Item
1. Condensed Consolidated Financial Statements
|
||
Condensed
Consolidated Balance Sheets at June 30, 2006 (unaudited) and December
31,
2005*
|
1
|
|
Unaudited
Condensed Consolidated Statements of Operations For the Six Months
and
Three Months ended June 30, 2006 and 2005
|
2
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows for the Six Months
Ended
June 30, 2006 and 2005
|
3
|
|
Notes
to Condensed Consolidated Financial Statements
|
4
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
13
|
|
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
18
|
|
Item
4. Controls and Procedures
|
18
|
|
PART
II - OTHER INFORMATION
|
||
Item
1. Legal Proceedings
|
19
|
|
Item
1A. Risk Factors
|
19
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
19
|
|
Item
3. Defaults upon Senior Securities
|
19
|
|
Item
4. Submission of Matters to a Vote of Security Holders
|
19
|
|
Item
5. Other Information
|
19
|
|
Item
6. Exhibits
|
19
|
|
20
|
||
Certifications
|
21
|
* |
The
Condensed Consolidated Balance Sheet at December 31, 2005 has been
derived
from the audited consolidated financial statements filed as an exhibit
to
our Report on Form 8-K on February 27,
2007.
|
June
30, 2006
|
December
31, 2005
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
3,858
|
$
|
2,023
|
|||
Accounts
receivable, net of allowance for doubtful accounts of $147 and
$145;
respectively
|
2,316
|
2,171
|
|||||
Prepaid
expenses and other current assets
|
487
|
510
|
|||||
Total
current assets
|
6,661
|
4,704
|
|||||
Property
and equipment, net
|
3,525
|
4,117
|
|||||
Other
assets
|
663
|
216
|
|||||
Total
assets
|
$
|
10,849
|
$
|
9,037
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
2,278
|
$
|
1,586
|
|||
Accrued
expenses
|
2,258
|
1,961
|
|||||
Accrued
sales taxes and regulatory fees
|
3,723
|
3,063
|
|||||
Current
portion of derivative financial instruments
|
4,636
|
1,246
|
|||||
Deferred
revenue
|
300
|
374
|
|||||
Total
current liabilities
|
13,195
|
8,230
|
|||||
Long
term liabilities:
|
|||||||
Derivative
financial instruments, less current portion
|
2,154
|
324
|
|||||
10%
Convertible notes, net of discount of $3,270
|
3,013
|
—
|
|||||
Total
long term liabilities
|
5,167
|
324
|
|||||
Total
liabilities
|
18,362
|
8,554
|
|||||
Preferred
stock, $.0001 par value; 5,000 shares authorized and redeemable;
0.120
Series B shares issued and outstanding, (stated value of $2,888;
liquidation value of $3,560 and $3,388, respectively)
|
2,888
|
2,888
|
|||||
Stockholders’
deficit:
|
|||||||
Common
stock, $.0001 par value; 100,000 shares authorized; 46,410 and
46,086
shares issued and issuable; 46,370 and 46,046 shares outstanding,
respectively
|
5
|
5
|
|||||
Additional
paid-in capital
|
161,190
|
160,219
|
|||||
Accumulated
deficit
|
(171,356
|
)
|
(161,833
|
)
|
|||
Deferred
compensation
|
—
|
(556
|
)
|
||||
(10,161
|
)
|
(2,165
|
)
|
||||
Less:
Treasury stock, 40 shares at cost
|
(240
|
)
|
(240
|
)
|
|||
Total
stockholders’ deficit
|
(10,401
|
)
|
(2,405
|
)
|
|||
Total
liabilities and stockholders’ deficit
|
$
|
10,849
|
$
|
9,037
|
|||
|
Six
Months Ended June 30,
|
Three
Months Ended June 30,
|
|||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Revenue
|
$
|
9,702
|
$
|
8,599
|
$
|
4,981
|
$
|
4,397
|
|||||
Cost
of revenue
|
6,836
|
7,692
|
3,350
|
4,006
|
|||||||||
Gross
margin
|
2,866
|
907
|
1,631
|
391
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development
|
474
|
576
|
203
|
263
|
|||||||||
Sales
and marketing
|
1,374
|
2,148
|
645
|
1,225
|
|||||||||
General
and administrative
|
7,458
|
6,670
|
2,805
|
3,456
|
|||||||||
Total
operating expense
|
9,306
|
9,394
|
3,653
|
4,944
|
|||||||||
Loss
from operations
|
(6,440
|
)
|
(8,487
|
)
|
(2,022
|
)
|
(4,553
|
)
|
|||||
Other
expense (income):
|
|||||||||||||
Interest
expense
|
2,415
|
1
|
777
|
1
|
|||||||||
Increase
in fair value of derivative financial instruments
|
579
|
80
|
602
|
38
|
|||||||||
Amortization
of deferred financing costs
|
129
|
—
|
129
|
—
|
|||||||||
Interest
income
|
(41
|
)
|
(33
|
)
|
(37
|
)
|
(30
|
)
|
|||||
Gain
on settlement with Gores
|
—
|
(379
|
)
|
—
|
—
|
||||||||
Total
other expense (income), net
|
3,082
|
(331
|
)
|
1,471
|
9
|
||||||||
Net
loss
|
(9,522
|
)
|
(8,156
|
)
|
(3,493
|
)
|
(4,562
|
)
|
|||||
Preferred
stock dividends
|
(172
|
)
|
(147
|
)
|
(87
|
)
|
(58
|
)
|
|||||
Preferred
stock deemed dividends
|
—
|
(1,282
|
)
|
—
|
—
|
||||||||
Net
loss attributable to common stockholders
|
$
|
(9,694
|
)
|
$
|
(9,585
|
)
|
$
|
(3,580
|
)
|
$
|
(4,620
|
)
|
|
Net
loss attributable to common stockholders per share:
|
|||||||||||||
Basic
and diluted
|
$
|
(0.21
|
)
|
$
|
(0.23
|
)
|
$
|
(0.08
|
)
|
$
|
(0.10
|
)
|
|
Weighted
average number of common shares:
|
|||||||||||||
Basic
and diluted
|
46,127
|
42,612
|
46,207
|
46,046
|
|||||||||
Six
Months Ended June 30,
|
|||||||
2006
|
2005
|
||||||
Cash
flows from Operating Activities:
|
|||||||
Net
loss
|
$
|
(9,522
|
)
|
$
|
(8,156
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Depreciation
and amortization
|
1,013
|
1,147
|
|||||
Amortization
of deferred financing costs
|
129
|
—
|
|||||
Other
expense recognized for the increase in the estimated fair value
of the
derivative financial instruments
|
579
|
81
|
|||||
Accretion
of discount on 10% Notes
|
369
|
—
|
|||||
Beneficial
conversion feature for 10% Notes
|
1,768
|
—
|
|||||
Gain
on settlement with Gores
|
—
|
(379
|
)
|
||||
Stock-based
compensation
|
530
|
573
|
|||||
Loss
on disposal of equipment
|
57
|
—
|
|||||
Increase
(decrease) in cash attributable to changes in assets and
liabilities:
|
|||||||
Accounts
receivable
|
(145
|
)
|
(299
|
)
|
|||
Prepaid
expenses and other current assets
|
23
|
(294
|
)
|
||||
Other
assets
|
205
|
2
|
|||||
Accounts
payable
|
692
|
(394
|
)
|
||||
Accrued
expenses, sales taxes and regulatory fees
|
1,104
|
516
|
|||||
Deferred
revenue
|
(74
|
)
|
243
|
||||
Net
cash used in operating activities
|
(3,272
|
)
|
(6,960
|
)
|
|||
Cash
flows from Investing Activities:
|
|||||||
Proceeds
from discontinued operations, including escrowed cash
|
—
|
3,087
|
|||||
Purchases
of property, equipment and leasehold improvements
|
(478
|
)
|
(1,011
|
)
|
|||
Net
cash (used in) provided by investing activities
|
(478
|
)
|
2,076
|
||||
Cash
flows from Financing Activities:
|
|||||||
Proceeds
from issuance of 10% Notes, net of financing costs of $595
|
5,585
|
—
|
|||||
Proceeds
from issuance of common stock and warrants
|
—
|
9,389
|
|||||
Proceeds
from exercise of warrants and options, net
|
—
|
74
|
|||||
Payments
on capital lease obligations
|
—
|
(35
|
)
|
||||
Net
cash provided by financing activities
|
5,585
|
9,428
|
|||||
Increase
in cash and cash equivalents
|
1,835
|
4,544
|
|||||
Cash
and cash equivalents at beginning of period
|
2,023
|
4,497
|
|||||
Cash
and cash equivalents at end of period
|
$
|
3,858
|
$
|
9,041
|
|||
Supplement
disclosures of cash flow information:
|
|||||||
Cash
paid during the period for:
|
|||||||
Interest
|
$
|
—
|
$
|
1
|
|||
Non-cash
investing and financing activities:
|
|||||||
Preferred
stock dividends
|
$
|
172
|
$
|
147
|
|||
Deferred
financing costs for 10% Notes incurred by issuance of placement
agent
warrants
|
296
|
—
|
|||||
Additional
10% Notes issued as payment for interest
|
103
|
—
|
|||||
Preferred
stock deemed dividends
|
—
|
1,282
|
|||||
Conversion
of Series B convertible preferred stock to common stock
|
—
|
2,000
|
|||||
Equity
issued as consideration for accrued preferred stock
dividends
|
—
|
183
|
Six
|
Three
|
||||||
Months
|
Months
|
||||||
Net
loss attributable to common stockholders, as reported
|
$
|
(9,585
|
)
|
$
|
(4,620
|
)
|
|
Add:
stock-based employee compensation expense included in reported
net
loss.
|
311
|
156
|
|||||
Deduct:
total stock-based employee compensation expense determined under
the fair
value based method
|
(847
|
)
|
(408
|
)
|
|||
Pro
forma net loss attributable to common stockholders
|
$
|
(
10,121
|
)
|
$
|
(4,872
|
)
|
|
Net
loss attributable to common stockholders per share:
|
|||||||
Basic
and diluted - as reported herein
|
$
|
(0.23
|
)
|
$
|
(0.10
|
)
|
|
Basic
and diluted - pro forma
|
$
|
(0.24
|
)
|
$
|
(0.11
|
)
|
Six
Months Ended June 30,
|
Three
Months Ended June 30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Risk
free interest rate
|
4.8%
|
|
3.9%
|
|
4.9%
|
|
3.8%
|
|
|||||
Expected
option lives
|
5
Years
|
5
Years
|
5
Years
|
5
Years
|
|||||||||
Expected
volatility
|
95.4%
|
|
109.5%
|
|
95.3%
|
|
108.6%
|
|
|||||
Estimated
forfeiture rate
|
30%
|
|
20%
|
|
30%
|
|
20%
|
|
|||||
Expected
dividend yields
|
None
|
None
|
None
|
None
|
|||||||||
Weighted
average grant date fair value of options
|
|
$0.30
|
|
$1.39
|
|
$0.29
|
|
$1.13
|
Outstanding
|
Exercisable
|
||||||||||||
|
Number
of Options
|
Weighted
Average
Exercise
Price
|
Number
of Options
|
Weighted
Average
Exercise
Price
|
|||||||||
Options
outstanding, January 1, 2006
|
4,996
|
$
|
2.51
|
3,613
|
$
|
2.92
|
|||||||
Granted
|
1,103
|
0.41
|
|||||||||||
Exercised
|
—
|
—
|
|||||||||||
Expired
|
(7
|
)
|
4.37
|
||||||||||
Forfeited
|
(681
|
)
|
1.48
|
||||||||||
Options
outstanding, June 30, 2006
|
5,411
|
$
|
2.51
|
3,865
|
$
|
2.79
|
Total
|
|||||||
Principal
of 10% Notes:
|
|||||||
March
2006 financing
|
$
|
5,665
|
|||||
April
2006 financing
|
515
|
||||||
Additional
10% Notes
|
103
|
||||||
$
|
6,283
|
||||||
Discount:
|
|||||||
Derivative
financial instrument - Series A Warrants
|
(2,873
|
)
|
|||||
Reduction
of exercise price and extension of expiration dates of
warrants
|
(766
|
)
|
|||||
(3,639
|
)
|
||||||
Accretion
of discount
|
369
|
||||||
(3,270
|
)
|
||||||
10%
Notes, net of discount
|
$
|
3,013
|
March
2006
|
April
2006
|
2006
|
||||||||
Cash
financing costs:
|
||||||||||
Placement
agent fees - Burnham Hill Partners
|
$
|
440
|
$
|
40
|
$
|
480
|
||||
Other
financing costs
|
105
|
10
|
115
|
|||||||
545
|
50
|
595
|
||||||||
Non-cash
financing costs:
|
||||||||||
Placement
agent warrants - Burnham Hill Partners
|
279
|
17
|
296
|
|||||||
Financing
costs charged to additional paid in capital
|
(101
|
)
|
(9
|
)
|
(110
|
)
|
||||
Total
financing costs
|
$
|
723
|
$
|
58
|
781
|
|||||
Accumulated
amortization
|
(129
|
)
|
||||||||
$
|
652
|
Dec.
31, 2005
|
2006
Activity
|
(Decrease)
increase in Fair Value
|
June
30, 2006
|
||||||||||
Derivative
financial instrument - February 2004 capital raise
|
$
|
1,570
|
$
|
—
|
$
|
(26
|
)
|
$
|
1,544
|
||||
Derivative
financial instrument - Beneficial conversion feature - 10%
notes
|
—
|
1,768
|
386
|
2,154
|
|||||||||
Derivative
financial instrument - Series A Warrants
|
—
|
2,873
|
219
|
3,092
|
|||||||||
1,570
|
$
|
4,641
|
$
|
579
|
6,790
|
||||||||
Current
portion
|
(1,246
|
)
|
(4,636
|
)
|
|||||||||
$
|
324
|
$
|
2,154
|
Six
Months Ended June 30,
|
Three
Months Ended June 30,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Beneficial
conversion feature for 10% Notes
|
$
|
1,768
|
$
|
—
|
$
|
182
|
$
|
—
|
|||||
Accretion
of discount on 10% Notes
|
369
|
—
|
369
|
—
|
|||||||||
Interest
on 10% Notes
|
155
|
—
|
155
|
—
|
|||||||||
Interest
expense for sales and use taxes and regulatory fees
|
123
|
—
|
71
|
—
|
|||||||||
Other
interest expense
|
—
|
1
|
—
|
1
|
|||||||||
$
|
2,415
|
$
|
1
|
$
|
777
|
$
|
1
|
Accrual
as of December 31, 2005
|
$
|
0
|
||
Provision
for severance
|
1,200
|
|||
Less:
amounts paid
|
(666
|
)
|
||
Accrual
as of June 30, 2006
|
$
|
534
|
(Unaudited)
|
|||||||||||||
Six
Months Ended
June
30,
|
Three
Months Ended
June
30 ,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Cost
of revenue
|
70.5
|
89.5
|
67.3
|
91.1
|
|||||||||
Gross
margin
|
29.5
|
10.5
|
32.7
|
8.9
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development
|
4.9
|
6.7
|
4.1
|
6.0
|
|||||||||
Sales
and marketing
|
14.2
|
25.0
|
12.9
|
27.9
|
|||||||||
General
and administrative
|
76.9
|
77.6
|
56.3
|
78.6
|
|||||||||
Total
operating expenses
|
96.0
|
109.3
|
73.3
|
112.5
|
|||||||||
Loss
from operations
|
(66.5
|
)
|
(98.8
|
)
|
(40.6
|
)
|
(103.6
|
)
|
|||||
Other
expense (income):
|
|||||||||||||
Interest
expense
|
24.8
|
──
|
15.5
|
──
|
|||||||||
Increase
in fair value of derivative financial instruments
|
6.0
|
0.9
|
12.1
|
0.9
|
|||||||||
Amortization
of deferred financing costs
|
1.3
|
──
|
2.6
|
──
|
|||||||||
Interest
income
|
(0.4
|
)
|
(0.4
|
)
|
(0.7
|
)
|
(0.7
|
)
|
|||||
Gain
on settlement with Gores
|
──
|
(4.4
|
)
|
──
|
──
|
||||||||
Total
other expense (income), net
|
31.7
|
(3.9
|
)
|
29.5
|
0.2
|
||||||||
Net
loss
|
(98.2
|
)
|
(94.9
|
)
|
(70.1
|
)
|
(103.8
|
)
|
|||||
Preferred
stock dividends
|
(1.8
|
)
|
(1.7
|
)
|
(1.7
|
)
|
(1.3
|
)
|
|||||
Preferred
stock deemed dividends
|
──
|
(14.9
|
)
|
──
|
──
|
||||||||
Net
loss attributable to common stockholders
|
(100.0
|
)%
|
(111.5
|
)%
|
(71.8
|
)%
|
(105.1
|
)%
|
Contractual
Obligations:
|
Total
|
Less
Than 1 Year
|
1-3
Years
|
3-5
Years
|
More
than 5 Years
|
|||||||||||
Long
term debt - 10% Notes
|
$
|
6,283
|
$
|
─
|
$
|
6,283
|
$
|
─
|
$
|
─
|
||||||
Derivative
liabilities
|
6,790
|
4,636
|
2,154
|
─
|
─
|
|||||||||||
Operating
lease obligations
|
447
|
312
|
133
|
2
|
─
|
|||||||||||
Commercial
commitments
|
9,899
|
4,948
|
4,784
|
167
|
─
|
|||||||||||
Total
|
$
|
23,419
|
$
|
9,896
|
$
|
13,354
|
$
|
169
|
$
|
─
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certificate of Chief Executive Officer
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
|
|
32.1
|
Certificate of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2
|
Certificate of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
GLOWPOINT,
INC.
Registrant
|
||
|
|
|
Date:
June 6, 2007
|
By: | /s/ Michael Brandofino |
Michael
Brandofino, Chief Executive Officer
(principal
executive officer)
|
Date:
June 6, 2007
|
By: | /s/ Edwin F. Heinen |
Edwin
F. Heinen, Chief Financial Officer
(principal
financial and accounting
officer)
|